The equivalent of a thallium binding residue from an archeal homolog controls cation interactions in brain glutamate transporters.
Glutamate transporters maintain low synaptic concentrations of neurotransmitter by coupling uptake to flux of other ions. Their transport cycle consists of two separate translocation steps, namely cotransport of glutamic acid with three Na(+) followed by countertransport of K(+). Two Tl(+) binding sites, presumed to serve as sodium sites, were observed in the crystal structure of a related archeal homolog and the side chain of a conserved aspartate residue contributed to one of these sites. We have mutated the corresponding residue of the eukaryotic glutamate transporters GLT-1 and EAAC1 to asparagine, serine, and cysteine. Remarkably, these mutants exhibited significant sodium-dependent radioactive acidic amino acid uptake when expressed in HeLa cells. Reconstitution experiments revealed that net uptake by the mutants in K(+)-loaded liposomes was impaired. However, with Na(+) and unlabeled L-aspartate inside the liposomes, exchange levels were around 50-90% of those by wild-type. In further contrast to wild-type, where either substrate or K(+) stimulated the anion conductance by the transporter, substrate but not K(+) modulated the anion conductance of the mutants expressed in oocytes. Both with wild-type EAAC1 and EAAC1-D455N, not only sodium but also lithium could support radioactive acidic amino acid uptake. In contrast, with D455S and D455C, radioactive uptake was only observed in the presence of sodium. Thus the conserved aspartate is required for transporter-cation interactions in each of the two separate translocation steps and likely participates in an overlapping sodium and potassium binding site.
Teichman
Shlomit
S
Department of Biochemistry, Hebrew University Hadassah Medical School, Jerusalem 91120, Israel.
Qu
Shaogang
S
Kanner
Baruch I
BI
D000818:Animals; D019843:Archaeal Proteins / Q000235:genetics / Q000378:metabolism; D001224:Aspartic Acid / Q000235:genetics / Q000378:metabolism / Q000494:pharmacology; D001665:Binding Sites; D001921:Brain / Q000378:metabolism*; D002412:Cations / Q000378:metabolism*; D027342:Excitatory Amino Acid Transporter 2 / Q000235:genetics / Q000378:metabolism* / Q000502:physiology; D050580:Excitatory Amino Acid Transporter 3 / Q000235:genetics / Q000378:metabolism / Q000502:physiology; D005260:Female; D006367:HeLa Cells; D006801:Humans; D017136:Ion Transport / Q000187:drug effects; D008081:Liposomes; D008094:Lithium / Q000378:metabolism / Q000494:pharmacology; D008564:Membrane Potentials / Q000187:drug effects; D009154:Mutation; D009865:Oocytes / Q000187:drug effects / Q000378:metabolism / Q000502:physiology; D011188:Potassium / Q000378:metabolism / Q000494:pharmacology; D011485:Protein Binding; D011817:Rabbits; D051381:Rats; D012964:Sodium / Q000378:metabolism / Q000494:pharmacology; D013793:Thallium / Q000378:metabolism*; D014982:Xenopus laevis
D019843:Archaeal Proteins; D002412:Cations; D027342:Excitatory Amino Acid Transporter 2; D050580:Excitatory Amino Acid Transporter 3; D008081:Liposomes; D001224:Aspartic Acid; D008094:Lithium; D012964:Sodium; D013793:Thallium; D011188:Potassium
Biochemistry. 1990 Dec 25;29(51):11209-14
1980217
Nature. 1992 Dec 3;360(6403):467-71
1280334
Philos Trans R Soc Lond B Biol Sci. 2009 Jan 27;364(1514):155-61
18977733
Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):751-5
9435265
Nature. 1992 Dec 3;360(6403):464-7
1448170
J Gen Physiol. 2001 Jun;117(6):547-62
11382805
J Biol Chem. 2006 Apr 14;281(15):10263-72
16478724
Neuron. 1998 Sep;21(3):623-32
9768848
Proc Natl Acad Sci U S A. 2005 Sep 6;102(36):12706-11
16123128
J Biol Chem. 2000 Nov 3;275(44):34106-13
10926932
Biochemistry. 2005 Sep 6;44(35):11913-23
16128593
Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1710-5
9990089
J Neurosci. 2000 Apr 15;20(8):2749-57
10751425
J Biol Chem. 2004 Jan 23;279(4):2513-9
14594797
J Neurochem. 2006 Oct;99(1):20-8
16831195
Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):4155-60
9108121
Biochemistry. 1978 Sep 19;17(19):3949-53
708689
Proc Natl Acad Sci U S A. 1986 Nov;83(21):8122-6
3095828
J Biol Chem. 1998 Jun 5;273(23):14231-7
9603927
Neuron. 1995 Sep;15(3):721-8
7546750
J Gen Physiol. 2007 Jun;129(6):527-39
17535962
J Biol Chem. 2008 Oct 17;283(42):28680-90
18678877
J Neurosci. 2007 Mar 14;27(11):2938-42
17360916
J Neurosci. 2005 Feb 16;25(7):1730-6
15716409
J Biol Chem. 2003 Jan 24;278(4):2585-92
12419818
J Biol Chem. 2002 Feb 8;277(6):3985-92
11724778
Biochemistry. 2008 Dec 2;47(48):12923-30
18986164
J Biol Chem. 1995 Jul 21;270(29):17093-7
7615503
Nature. 2007 Jan 25;445(7126):387-93
17230192
J Gen Physiol. 2007 Apr;129(4):331-44
17389249
J Biol Chem. 2006 Sep 22;281(38):27905-15
16870620
Proc Natl Acad Sci U S A. 2007 Nov 13;104(46):18025-30
17991780
Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14282-7
10588697
Biochemistry. 1992 Feb 25;31(7):1974-9
1536839
Nature. 1996 Oct 17;383(6601):634-7
8857541
Nature. 2004 Oct 14;431(7010):811-8
15483603
Biochemistry. 1982 Nov 23;21(24):6327-30
6129891
Nature. 1987 Jun 25-Jul 1;327(6124):707-9
2885752
J Neurosci. 1994 Sep;14(9):5559-69
7521911
Nature. 2007 Dec 13;450(7172):1043-9
18075585
J Biol Chem. 1995 Jul 14;270(28):17017-24
7622523
J Neurosci. 2007 Mar 14;27(11):2943-7
17360917
Nature. 1995 Jun 15;375(6532):599-603
7791878
J Biol Chem. 2000 Dec 1;275(48):37436-42
10978338
J Biol Chem. 2000 Mar 31;275(13):9684-9
10734120
J Biol Chem. 2001 Nov 2;276(44):40396-401
11479303
J Neurosci. 1998 Oct 1;18(19):7650-61
9742136
J Neurosci. 1998 Dec 1;18(23):9620-8
9822723
Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9706-11
10931942
J Biol Chem. 1997 Jan 17;272(3):1703-8
8999849
J Biol Chem. 1951 Nov;193(1):265-75
14907713
Methods Enzymol. 1987;154:367-82
3323813
J Neurosci. 1998 Sep 15;18(18):7099-110
9736633
Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):15977-82
12461183